Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism.

echocardiographic markers left ventricular outflow tract velocity time integral (LVOT VTI) prognostic marker pulmonary embolism reperfusion therapy

Journal

Pulmonary circulation
ISSN: 2045-8932
Titre abrégé: Pulm Circ
Pays: United States
ID NLM: 101557243

Informations de publication

Date de publication:
Historique:
received: 19 05 2020
accepted: 07 08 2020
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 17 10 2020
Statut: epublish

Résumé

Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versus anticoagulation alone and their effect on left ventricular outflow tract velocity time integral. This was a retrospective cohort study of subjects ≥18 years of age with a diagnosis of submassive or massive pulmonary embolism. The primary outcome was the percent change in left ventricular outflow tract velocity time integral between pre- and post-treatment echocardiograms. Ultrasound-accelerated thrombolysis compared to anticoagulation had a greater improvement in left ventricular outflow tract velocity time integral, measured by percent change. No significant change was noted between the ultrasound-accelerated thrombolysis and systemic thrombolysis nor systemic thrombolysis and anticoagulation groups. Pulmonary artery systolic pressure only showed a significant reduction in the ultrasound-accelerated thrombolysis versus anticoagulation group. The percent change of right ventricular to left ventricular ratios was improved when systemic thrombolysis was compared to both ultrasound-accelerated thrombolysis and anticoagulation. In this retrospective study of submassive or massive pulmonary embolisms, left ventricular outflow tract velocity time integral demonstrated greater improvement in patients treated with ultrasound-accelerated thrombolysis as compared to anticoagulation alone, a finding not seen with systemic thrombolysis. While this improvement in left ventricular outflow tract velocity time integral parallels the trend seen in mortality outcomes across the three groups, it only correlates with changes seen in pulmonary artery systolic pressure, not in other markers of echocardiographic right ventricular dysfunction (tricuspid annular plane systolic excursion and right ventricular to left ventricular ratios). Changes in left ventricular outflow tract velocity time integral, rather than echocardiographic markers of right ventricular dysfunction, may be considered a more useful prognostic marker of both dysfunction and improvement after reperfusion therapy.

Identifiants

pubmed: 33062260
doi: 10.1177/2045894020953724
pii: 10.1177_2045894020953724
pmc: PMC7534090
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2045894020953724

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL076139
Pays : United States

Informations de copyright

© The Author(s) 2020.

Références

Lancet. 1993 Feb 27;341(8844):507-11
pubmed: 8094768
Vasc Med. 2020 Apr;25(2):133-140
pubmed: 31709912
N Engl J Med. 2004 May 27;350(22):2257-64
pubmed: 15163775
Cardiovasc Ultrasound. 2017 Jul 3;15(1):18
pubmed: 28673293
Circulation. 2011 Apr 26;123(16):1788-830
pubmed: 21422387
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):754-760
pubmed: 28145042
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401-1410
pubmed: 30025734
J Thromb Haemost. 2014 Jul;12(7):1020-7
pubmed: 24766779
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-92
pubmed: 26315743
Circulation. 2014 Jan 28;129(4):479-86
pubmed: 24226805
Chest. 2017 May;151(5):1058-1068
pubmed: 27932051
Arch Med Sci. 2016 Oct 1;12(5):1008-1014
pubmed: 27695491
Chest. 2015 Sep;148(3):667-673
pubmed: 25856269
Am J Med. 2016 Aug;129(8):879.e19-25
pubmed: 26925811
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681

Auteurs

David Antoine (D)

Department of Pharmacy, Northwestern Memorial Hospital, Chicago, USA.

Taylor Chuich (T)

Department of Pharmacy, NewYork-Presbyterian, New York, USA.

Ruben Mylvaganam (R)

Division of Pulmonary and Critical Care, Northwestern Memorial Hospital, Chicago, USA.

Chris Malaisrie (C)

Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Chicago, USA.

Benjamin Freed (B)

Division of Cardiology, Northwestern Memorial Hospital, Chicago, USA.

Michael Cuttica (M)

Division of Pulmonary Hypertension, Northwestern Memorial Hospital, Chicago, USA.

Daniel Schimmel (D)

Divison of Interventional Cardiology, Bluhm Cardiovascular Institute, Chicago, USA.

Classifications MeSH